NRC
SLXP

North Run Capital’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

North Run Capital’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-490,000
Closed -$56.3M – 31
2014
Q4 		$56.3M Buy
+490,000
New +$56.3M 5.01% 8